Remove 2023 Remove Government Remove Individual Remove Insurance
article thumbnail

Have Job-Based Health Coverage at 65? You May Still Want To Sign Up for Medicare

Physician's Weekly

When Alyne Diamond fell off a horse in August 2023 and broke her back, her employer-based health plan through UnitedHealthcare covered her emergency care in Aspen, Colorado. Since she was still working, she thought her employer health insurance plan would cover her. This time, though, the insurance coverage wasn’t routine.

article thumbnail

Silence Isn’t Golden: Two Executives Convicted in First Criminal Prosecution Under the Consumer Product Safety Act

FDA Law Blog

17, 2023, the Department of Justice (DOJ) announced the first-ever conviction of two corporate executives in a criminal prosecution for failure to report a consumer product defect under the CPSA. (the Then, earlier this year, in April 2023, Gree USA, Inc., The government charged these individuals with conspiracy (18 U.S.C. §

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law Blog

11, 2023 ( DOJ Press Release ). 6, 2023 ( DOJ Press Release ). The government asserted additional allegations that are outside our scope. District Court for the Western District of Texas imposed a $275,000 civil penalty on Zarzamora Healthcare LLC, in San Antonio, and its pharmacist-owner. Zarzamora Press Release.

article thumbnail

Prescribing Red Flags: Pharmacists Be Wary of What the Doctor Orders

FDA Law Blog

For a controlled substance prescription to be effective, that is valid, it must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of their professional practice. Attorneys Office, Northern District of Illinois, April 21, 2025. 81, 86, 251. 81, 89, 251.

article thumbnail

Pharmacists in Florida (and Elsewhere): Waive Prescribing Red Flags at Your Peril

FDA Law Blog

After issuing an Order to Show Cause and Immediate Suspension of Registration in September 2022, and an administrative hearing in March 2023, DEA adopted the hearing Administrative Law Judge’s (“ALJ’s”) Recommended Decision to revoke Coconut Grove’s registration based on the public interest factors of 21 U.S.C. 823(g)(1). Patient J.C.’s

article thumbnail

Guiding an Improved Dementia Experience (GUIDE) Model: A Podcast with Malaz Boustani and Diane Ty

GeriPal

You come over to the clinic, you go to the hospital, you provide service, and the insurance and you negotiate how much you’re going to get paid. That never happens in CMS and other health insurance. Just to let you know, Eric, we have to give the credit to our federal government. Right now, the pay per service.

article thumbnail

Drug Pricing Reform Gathers Steam (Part 2)

FDA Law Blog

This bill, which addresses numerous areas of the economy, public health, and government regulation, includes Subtitle E, Drug Pricing. PART 1: MAXIMUM FAIR PRICE PAYMENT LIMITATION UNDER MEDICARE PARTS B AND D AND THE COMMERCIAL INSURANCE MARKET. Subtitle E is a slightly modified version of H.R. 3, the Elijah E. 8126 with a lower MFP.